raloxifene hydrochloride has been researched along with Liver Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, Y; Hori, T; Hosokawa, Y; Kozawa, O; Matsushima-Nishiwaki, R; Tachi, J; Yamada, N | 1 |
| Jou, D; Li, C; Li, H; Li, S; Lin, J; Lin, L; Liu, T; Lü, J; Ma, H; Wang, Y; Yan, D; Zhang, C; Zhao, C | 1 |
| Bisson, WH; Jang, HS; Koch, DC; Kolluri, SK; O'Donnell, EF | 1 |
| Bolton, JL; Dietz, BM; Dunlap, T; Kastrati, I; Lantvit, DD; Overk, CR; Qin, Z; Thatcher, GR; Yao, P; Yu, B | 1 |
| Andersson-Ross, C; Barkhem, T; Höglund, M; Nilsson, S | 1 |
| Folse, DS; Liehr, JG; Roy, D | 1 |
6 other study(ies) available for raloxifene hydrochloride and Liver Neoplasms
| Article | Year |
|---|---|
SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Estrogen Receptor beta; Estrogens; Gene Expression Regulation, Neoplastic; Humans; Indoles; Liver Neoplasms; Proto-Oncogene Proteins c-akt; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured | 2022 |
Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytokine Receptor gp130; Cytokines; Disease Models, Animal; Humans; Interleukin-6; Leukemia Inhibitory Factor; Liver Neoplasms; Mice; Phosphorylation; Protein Transport; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT6 Transcription Factor; Xenograft Model Antitumor Assays | 2017 |
The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells.
Topics: Animals; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Female; Humans; Liver Neoplasms; Mice; Protein Binding; Raloxifene Hydrochloride; Receptors, Aryl Hydrocarbon; Receptors, Estrogen | 2014 |
Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms.
Topics: Animals; Antioxidants; Breast Neoplasms; Carcinoma, Hepatocellular; Chemoprevention; Female; Humans; Liver; Liver Neoplasms; Luciferases; Mice; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Peroxides; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Thiophenes; Tumor Cells, Cultured | 2007 |
Characterization of the "estrogenicity" of tamoxifen and raloxifene in HepG2 cells: regulation of gene expression from an ERE controlled reporter vector versus regulation of the endogenous SHBG and PS2 genes.
Topics: Alkaline Phosphatase; Carcinoma, Hepatocellular; Clone Cells; Estradiol; Estradiol Congeners; Estrogen Antagonists; Ethinyl Estradiol; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Kinetics; Liver Neoplasms; Piperidines; Placenta; Pregnancy; Protein Biosynthesis; Proteins; Raloxifene Hydrochloride; Receptors, Estrogen; Recombinant Fusion Proteins; Sex Hormone-Binding Globulin; Tamoxifen; Tetradecanoylphorbol Acetate; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1997 |
Lack of effectiveness of antiestrogens RU 39,411 or keoxifene in the prevention of estrogen-induced tumors in Syrian hamsters.
Topics: Animals; Cricetinae; Estradiol; Estrogen Antagonists; Kidney Neoplasms; Liver Neoplasms; Male; Mesocricetus; Piperidines; Raloxifene Hydrochloride; Testicular Neoplasms | 1992 |